61.91
price down icon1.83%   -0.5446
 
loading
前日終値:
$62.45
開ける:
$61.79
24時間の取引高:
353.55K
Relative Volume:
0.11
時価総額:
$8.07B
収益:
$638.78M
当期純損益:
$-22.66M
株価収益率:
-354.96
EPS:
-0.1744
ネットキャッシュフロー:
$122.18M
1週間 パフォーマンス:
-5.27%
1か月 パフォーマンス:
+29.70%
6か月 パフォーマンス:
+165.98%
1年 パフォーマンス:
+337.61%
1日の値動き範囲:
Value
$61.02
$62.33
1週間の範囲:
Value
$58.70
$65.74
52週間の値動き範囲:
Value
$11.16
$66.94

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1083)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,178
Name
Twitter
@10xgenomics
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

Compare TXG vs VEEV, BTSG, TEM, HQY

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TXG icon
TXG
10 X Genomics Inc
61.90 8.32B 638.78M -22.66M 122.18M -0.1744
VEEV icon
VEEV
Veeva Systems Inc
283.99 40.70B 3.32B 941.65M 1.64B 5.6161
BTSG icon
BTSG
Brightspring Health Services Inc
59.74 11.78B 13.65B 169.86M 412.12M 1.0758
TEM icon
TEM
Tempus Ai Inc
63.70 12.03B 1.36B -302.91M -219.93M -1.7182
HQY icon
HQY
Healthequity Inc
98.24 8.72B 1.34B 230.70M 440.96M 2.6695

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-31 アップグレード William Blair Mkt Perform → Outperform
2025-12-11 ダウングレード Citigroup Buy → Neutral
2025-12-02 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-09-11 開始されました Piper Sandler Neutral
2025-02-13 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
Aug 20, 2026

10x Genomics: The Turnaround Is Real, But Atera Now Has To Deliver (Rating Upgrade) (TXG) - Seeking Alpha

Aug 20, 2026
pulisher
Aug 19, 2026

Federal Circuit Upholds PTAB Obviousness Rulings Against Single Cell Sequencing Patents - IPWatchdog.com

Aug 19, 2026
pulisher
Aug 19, 2026

10x Genomics Gains as Investors Extend Post-Earnings Rally on Atera Demand - Quiver Quantitative

Aug 19, 2026
pulisher
Aug 19, 2026

10x Genomics’ Bid to Revive Patents Rejected by Federal Circuit - Bloomberg Law News

Aug 19, 2026
pulisher
Aug 19, 2026

10x Genomics (NASDAQ:TXG) Reaches New 52-Week HighWhat's Next? - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

10x Genomics stock hits 52-week high at $60.73 By Investing.com - Investing.com Australia

Aug 19, 2026
pulisher
Aug 19, 2026

10x Genomics stock hits 52-week high at $60.73 - Investing.com

Aug 19, 2026
pulisher
Aug 19, 2026

Bank of America Corp DE Has $20.48 Million Position in 10x Genomics $TXG - MarketBeat

Aug 19, 2026
pulisher
Aug 18, 2026

Director Sarah Teichmann Sells 7,551 Shares of 10x Genomics Inc (TXG) - GuruFocus

Aug 18, 2026
pulisher
Aug 17, 2026

A Look at 10x Genomics Inc (TXG) After 3.4% Gain -- GF Value $18 - GuruFocus

Aug 17, 2026
pulisher
Aug 17, 2026

10x Genomics Inc (TXG) (Q2 2026) Earnings Call Highlights: Atera Launch Drives Record Demand Amidst Transition - GuruFocus

Aug 17, 2026
pulisher
Aug 17, 2026

10x Genomics (NASDAQ: TXG) director sells under 10b5-1 plan - Stock Titan

Aug 17, 2026
pulisher
Aug 17, 2026

7 Best Genomics Stocks for 2026 and How to Invest - The Motley Fool

Aug 17, 2026
pulisher
Aug 16, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 16, 2026
pulisher
Aug 15, 2026

10x Genomics (TXG) Dips 3.5% to $56.09 as Support at $53.29 Comes Into ViewTrend Reversal Picks - Vinanet

Aug 15, 2026
pulisher
Aug 15, 2026

5 Revealing Analyst Questions From 10x Genomics’s Q2 Earnings Call - Yahoo Finance

Aug 15, 2026
pulisher
Aug 14, 2026

Cathie Wood’s ARK sells 10X Genomics stock, buys Perceptive Capital By Investing.com - Investing.com Canada

Aug 14, 2026
pulisher
Aug 14, 2026

Cathie Wood’s ARK sells 10X Genomics stock, buys Perceptive Capital - Investing.com

Aug 14, 2026
pulisher
Aug 14, 2026

A Look at 10x Genomics Inc (TXG) After 3.6% Decline -- GF Value $18.38 vs Price $56.09 - GuruFocus

Aug 14, 2026
pulisher
Aug 14, 2026

TXG (TXG) insider schedules sale of common stock and notes prior sale - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

ARK Investment Management (TXG) reports 10.0M-share position in 10x Genomics - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

10x Genomics, Inc.: Financial Data Forecasts Estimates and Expectations | TXG | US88025U1097 - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

10x Genomics director John Stuelpnagel sells $1.15m in shares - Investing.com

Aug 14, 2026
pulisher
Aug 14, 2026

10x Genomics director John Stuelpnagel sells $1.15m in shares By Investing.com - Investing.com Australia

Aug 14, 2026
pulisher
Aug 13, 2026

10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares in August 2026 SEC Filing - Kalkine Media

Aug 13, 2026
pulisher
Aug 13, 2026

Insider Selling: 10x Genomics (NASDAQ:TXG) Director Sells 20,000 Shares of Stock - MarketBeat

Aug 13, 2026
pulisher
Aug 13, 2026

10x Genomics, Inc. SEC Filing (Aug 13, 2026) - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

10x Genomics (TXG) director John Stuelpnagel sells 20,000 shares in August 11 trades - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Why 10x Genomics (TXG) Is Up 21.7% After Raising 2026 Outlook Despite Q2 Revenue Drop - simplywall.st

Aug 13, 2026
pulisher
Aug 13, 2026

10x Genomics $TXG Shares Acquired by Sei Investments Co. - MarketBeat

Aug 13, 2026
pulisher
Aug 12, 2026

US$49.54That's What Analysts Think 10x Genomics, Inc. (NASDAQ:TXG) Is Worth After These Results - webull.com

Aug 12, 2026
pulisher
Aug 11, 2026

10x Genomics, Inc. SEC Filing (Aug 11, 2026) - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

10x Genomics, Inc. (TXG) Stock Analysis: Navigating the High Valuation and Market Dynamics - DirectorsTalk Interviews

Aug 11, 2026
pulisher
Aug 10, 2026

Is 10x Genomics Inc (TXG) Overvalued After 12.3% Rally? GF Value - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

10x Genomics, Inc. (TXG) stock price, news, quote and history - Yahoo Finance UK

Aug 10, 2026
pulisher
Aug 10, 2026

10x Genomics (NASDAQ:TXG) Trading Up 7.1%Time to Buy? - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

TXG Stock Jumps As Earnings Beat Triggers Analyst Upgrades - StocksToTrade

Aug 10, 2026
pulisher
Aug 10, 2026

10X GENOMICS INC : CANACCORD GENUITY RAISES TARGET PRICE TO $60 FROM $50 - Bitget

Aug 10, 2026
pulisher
Aug 09, 2026

10x Genomics Stock Jumps As Analysts Hike Price Targets - timothysykes.com

Aug 09, 2026
pulisher
Aug 09, 2026

10X Genomics Inc (TXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 09, 2026
pulisher
Aug 08, 2026

Enterprise value to EBIT forward of 10x Genomics Inc Class A – BMV:TXG - TradingView

Aug 08, 2026
pulisher
Aug 08, 2026

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), 10x Genomics (TXG) and Teleflex (TFX) - The Globe and Mail

Aug 08, 2026
pulisher
Aug 08, 2026

TXG Jumps As 10x Genomics Price Targets Surge After Q2 Beat - timothysykes.com

Aug 08, 2026
pulisher
Aug 07, 2026

10X Genomics Inc (TXG) Stock News Today - tradingkey.com

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics, Inc. Stock 12‑Month Price Target Raised to $47.23, Implies 4% Upside - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics Q2 Earnings Call Highlights - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics stock hits 52-week high at 50.36 USD - Investing.com

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics: Atera Sees ‘Extraordinary’ Customer Response As Multiomics Strategy Expands - Pulse 2.0

Aug 07, 2026
pulisher
Aug 07, 2026

10X GENOMICS, INC. : JEFFERIES RAISES TARGET PRICE TO $53 FROM $40 - Moomoo

Aug 07, 2026
pulisher
Aug 07, 2026

10x Genomics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 07, 2026

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
HQY HQY
$98.35
price up icon 0.69%
$91.73
price down icon 1.12%
WAY WAY
$26.00
price down icon 0.65%
$26.74
price down icon 0.21%
TEM TEM
$64.11
price up icon 1.48%
大文字化:     |  ボリューム (24 時間):